News
The HOST-BR trial found that a 3-month dual antiplatelet therapy regimen after percutaneous coronary intervention balances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback